PIK3CA and tumor of uterus: Targeted sequencing in primary uterine tumor revealed an activating PIK3CA hotspot exon 2 mutation (c.263G>A) with an allelic ratio of 34% and hotspot exon 21 mutation (c c.3129G>T) with an allelic ratio of 33%.